September 18, 2024
September 18, 2024
Infectious Conjunctivitis May Have a Biomarker
September 18, 2024
Assessing the Impact of iRORA Lesions on Retina Sensitivity and Function
September 25, 2024
Is CTG18.1 Instability the Key to FECD Progression?
September 18, 2024
Disc Changes Did Not Impact Vision-Related QoL in OHTS
September 17, 2024
Can Hair Dye Cause Retinopathy?
Latest Headlines
View More
October 07, 2024
Euretina 2024: 3-Month Outcomes from VOYAGER
Daily News
Stay up to date with the latest clinical headlines.
Trending Now
1
Sickle Cell Drug Shows Promise in Stabilizing Vision in Rare Genetic Disease
2
Infectious Conjunctivitis May Have a Biomarker
3
Clobetasol Soon to be Available in the US
4
Study Finds Significant Association between 17 Drugs and Drug-Related Keratitis
5
Can L-DOPA Protect Against nAMD?
6
Proposed Aflibercept Biosimilar Shows Comparable Safety and Efficacy to Eylea for nAMD
Conference Coverage
2024 Miami Breast Cancer Conference
Clinical Guidelines
View More
October 01, 2024
Clinical Trial Update October 2024
October 01, 2024
Coding: Separate Procedures and NCCI Bundles
October 01, 2024
The Vital Role We Play in Advocacy
Commentary & Perspectives
View More
September 24, 2024
Clobetasol Soon to be Available in the US
FDA & Government News
View More
September 24, 2024
SKG1108 Receives FDA Orphan Drug Designation
September 24, 2024
EDVI Act Supports More Comprehensive Eye Care for Children
September 23, 2024
MCO-010 Advances to Phase 3 for Stargardt Macular Degeneration
August 27, 2024
PCPs Play Important Role in Glaucoma Screening
Business Management
View More
October 01, 2024
Win the Battle for Positive Change
September 01, 2023
EMR and MIPS compliance
December 01, 2023
GUEST EDITORIAL
November 01, 2023